GERON CORP Revenue
GERON CORP (GERN) reported Revenue of $57.48 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-05
- GERON CORP revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $57.48M, a 17.22% increase year-over-year.
- GERON CORP revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $51.84M, a 30.89% increase year-over-year.
- GERON CORP revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $47.23M, a 67.05% increase year-over-year.
- GERON CORP revenue from contract with customer, excluding assessed tax for the quarter ending 2025-06-30 was $49.04M, a 5459.64% increase year-over-year.
- GERON CORP revenue from contract with customer, excluding assessed tax for fiscal 2023 was $237.00K, a 60.23% decline from fiscal 2022.
- GERON CORP revenue from contract with customer, excluding assessed tax for fiscal 2022 was $596.00K, a 57.21% decline from fiscal 2021.
- GERON CORP revenue from contract with customer, excluding assessed tax for fiscal 2021 was $1.39M, a 450.59% increase from fiscal 2020.
- GERON CORP revenue from contract with customer, excluding assessed tax for fiscal 2020 was $253.00K, a 45.00% decline from fiscal 2019.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $57.48M 10-Q · filed 2026-08-05 | $109.32M 10-Q · filed 2026-08-05 | ||
| 2026-03-31 | $51.84M 10-Q · filed 2026-05-06 | |||
| 2025-09-30 | $47.23M 10-Q · filed 2025-11-07 | $96.26M derived: sum of 2 quarters · filed 2026-08-05 | $135.87M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $49.04M 10-Q · filed 2026-08-05 | $88.64M 10-Q · filed 2026-08-05 | ||
| 2025-03-31 | $39.60M 10-Q · filed 2026-05-06 | |||
| 2024-09-30 | $28.27M 10-Q · filed 2025-11-07 | $29.15M derived: sum of 2 quarters · filed 2025-11-07 | $29.46M 10-Q · filed 2025-11-07 | $29.48M derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | $882.00K 10-Q · filed 2025-08-06 | $1.19M 10-Q · filed 2025-08-06 | $1.21M derived: sum of 3 quarters · filed 2025-08-06 | $1.37M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $304.00K 10-Q · filed 2025-05-07 | $327.00K derived: sum of 2 quarters · filed 2025-05-07 | $491.00K derived: sum of 3 quarters · filed 2025-05-07 | $520.00K derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | $23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $187.00K derived: sum of 2 quarters · filed 2024-11-07 | $216.00K derived: sum of 3 quarters · filed 2024-11-07 | $237.00K 10-K · filed 2024-02-28 |
| 2023-09-30 | $164.00K 10-Q · filed 2024-11-07 | $193.00K derived: sum of 2 quarters · filed 2024-11-07 | $214.00K 10-Q · filed 2024-11-07 | $317.00K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $29.00K 10-Q · filed 2024-08-08 | $50.00K 10-Q · filed 2024-08-08 | $153.00K derived: sum of 3 quarters · filed 2024-08-08 | $450.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $21.00K 10-Q · filed 2024-05-02 | $124.00K derived: sum of 2 quarters · filed 2024-05-02 | $421.00K derived: sum of 3 quarters · filed 2024-05-02 | $494.00K derived: sum of 4 quarters · filed 2024-05-02 |
| 2022-12-31 | $103.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $400.00K derived: sum of 2 quarters · filed 2024-02-28 | $473.00K derived: sum of 3 quarters · filed 2024-02-28 | $596.00K 10-K · filed 2024-02-28 |
| 2022-09-30 | $297.00K 10-Q · filed 2023-11-02 | $370.00K derived: sum of 2 quarters · filed 2023-11-02 | $493.00K 10-Q · filed 2023-11-02 | $1.53M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $73.00K 10-Q · filed 2023-08-03 | $196.00K 10-Q · filed 2023-08-03 | $1.24M derived: sum of 3 quarters · filed 2024-02-28 | $1.34M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $123.00K 10-Q · filed 2023-05-11 | $1.16M derived: sum of 2 quarters · filed 2024-02-28 | $1.27M derived: sum of 3 quarters · filed 2024-02-28 | $1.38M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $1.15M derived: sum of 2 quarters · filed 2024-02-28 | $1.26M derived: sum of 3 quarters · filed 2024-02-28 | $1.39M 10-K · filed 2024-02-28 |
| 2021-09-30 | $109.00K 10-Q · filed 2022-11-07 | $216.00K derived: sum of 2 quarters · filed 2022-11-07 | $353.00K 10-Q · filed 2022-11-07 | $403.00K derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-06-30 | $107.00K 10-Q · filed 2022-08-11 | $244.00K 10-Q · filed 2022-08-11 | $294.00K derived: sum of 3 quarters · filed 2023-03-16 | $402.00K derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-03-31 | $137.00K 10-Q · filed 2022-05-09 | $187.00K derived: sum of 2 quarters · filed 2023-03-16 | $295.00K derived: sum of 3 quarters · filed 2023-03-16 | $338.00K derived: sum of 4 quarters · filed 2023-03-16 |
| 2020-12-31 | $50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $158.00K derived: sum of 2 quarters · filed 2023-03-16 | $201.00K derived: sum of 3 quarters · filed 2023-03-16 | $253.00K 10-K · filed 2023-03-16 |
| 2020-09-30 | $108.00K 10-Q · filed 2021-11-09 | $151.00K derived: sum of 2 quarters · filed 2021-11-09 | $203.00K 10-Q · filed 2021-11-09 | $374.00K derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $43.00K 10-Q · filed 2021-08-16 | $95.00K 10-Q · filed 2021-08-16 | $266.00K derived: sum of 3 quarters · filed 2021-08-16 | $397.00K derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $52.00K 10-Q · filed 2021-05-10 | $223.00K derived: sum of 2 quarters · filed 2021-05-10 | $354.00K derived: sum of 3 quarters · filed 2021-05-10 | $455.00K derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | $171.00K 10-K · filed 2020-03-12 | $302.00K derived: sum of 2 quarters · filed 2020-11-05 | $403.00K derived: sum of 3 quarters · filed 2020-11-05 | $460.00K 10-K · filed 2022-03-10 |
| 2019-09-30 | $131.00K 10-Q · filed 2020-11-05 | $232.00K derived: sum of 2 quarters · filed 2020-11-05 | $289.00K 10-Q · filed 2020-11-05 | $664.00K derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $101.00K 10-Q · filed 2020-08-06 | $158.00K 10-Q · filed 2020-08-06 | $533.00K derived: sum of 3 quarters · filed 2020-08-06 | $698.00K derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $57.00K 10-Q · filed 2020-05-28 | $432.00K derived: sum of 2 quarters · filed 2020-05-28 | $597.00K derived: sum of 3 quarters · filed 2020-05-28 | $805.00K derived: sum of 4 quarters · filed 2020-05-28 |
| 2018-12-31 | $375.00K 10-K · filed 2020-03-12 | $540.00K derived: sum of 2 quarters · filed 2020-03-12 | $748.00K derived: sum of 3 quarters · filed 2020-03-12 | $1.07M 10-K · filed 2021-03-11 |
| 2018-09-30 | $165.00K 10-K · filed 2020-03-12 | $373.00K derived: sum of 2 quarters · filed 2020-03-12 | $691.00K 10-Q · filed 2019-11-06 | $882.00K derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | $208.00K 10-K · filed 2020-03-12 | $526.00K 10-Q · filed 2019-08-01 | $717.00K derived: sum of 3 quarters · filed 2020-03-12 | $880.00K derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | $318.00K 10-K · filed 2020-03-12 | $509.00K derived: sum of 2 quarters · filed 2020-03-12 | $672.00K derived: sum of 3 quarters · filed 2020-03-12 | $846.00K derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | $191.00K 10-K · filed 2019-03-07 | $354.00K derived: sum of 2 quarters · filed 2019-03-07 | $528.00K derived: sum of 3 quarters · filed 2019-03-07 | $1.06M 10-K · filed 2020-03-12 |
| 2017-09-30 | $163.00K 10-K · filed 2019-03-07 | $337.00K derived: sum of 2 quarters · filed 2019-03-07 | $874.00K derived: sum of 3 quarters · filed 2019-03-07 | |
| 2017-06-30 | $174.00K 10-K · filed 2019-03-07 | $711.00K derived: sum of 2 quarters · filed 2019-03-07 | ||
| 2017-03-31 | $537.00K 10-K · filed 2019-03-07 | |||
| 2016-12-31 | $6.16M 10-K · filed 2019-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |